Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Atul Ltd

ATUL
NSE
6,812.00
0.63%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Atul Ltd

ATUL
NSE
6,812.00
0.63%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
20,056Cr
Close
Close Price
6,812.00
Industry
Industry
Dyes & Pigments
PE
Price To Earnings
29.58
PS
Price To Sales
3.20
Revenue
Revenue
6,274Cr
Rev Gr TTM
Revenue Growth TTM
12.36%
PAT Gr TTM
PAT Growth TTM
38.20%
Peer Comparison
How does ATUL stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
ATUL
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue
RevenueCr
1,1821,1941,1381,2121,3221,3931,4171,4521,4781,5521,5741,670
Growth YoY
Revenue Growth YoY%
-20.0-19.7-10.31.411.816.724.519.811.811.411.115.1
Expenses
ExpensesCr
1,0001,0399861,0651,0991,1501,1931,2291,2431,2841,3271,389
Operating Profit
Operating ProfitCr
182155152148223243224223236267247281
OPM
OPM%
15.413.013.312.216.917.415.815.415.917.215.716.8
Other Income
Other IncomeCr
102417161635195028504092
Interest Expense
Interest ExpenseCr
222559455544
Depreciation
DepreciationCr
525461767778818282818079
PBT
PBTCr
13812410583158191158186177231203289
Tax
TaxCr
363233244651415645494078
PAT
PATCr
102917259112140117130132182164211
Growth YoY
PAT Growth YoY%
-37.6-38.4-30.0-36.29.852.962.5121.318.130.739.762.2
NPM
NPM%
8.67.66.34.88.510.08.39.09.011.810.412.6
EPS
EPS
35.030.624.019.838.046.536.943.043.460.954.671.4

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue
RevenueCr
2,6562,5952,8343,2964,0384,0933,7315,0815,4284,7265,5836,274
Growth
Revenue Growth%
-2.39.216.322.51.4-8.836.26.8-12.918.112.4
Expenses
ExpensesCr
2,2552,1352,3242,7913,2713,1912,8144,1694,6534,0894,6705,243
Operating Profit
Operating ProfitCr
4014595095057679029179117756379131,031
OPM
OPM%
15.117.718.015.319.022.024.617.914.313.516.416.4
Other Income
Other IncomeCr
1039573040831108411968120209
Interest Expense
Interest ExpenseCr
2628251379998112417
Depreciation
DepreciationCr
606695110119130136177198243317322
PBT
PBTCr
326404446412680845882810688451692901
Tax
TaxCr
99130123131244175222205181127194211
PAT
PATCr
226274323281436671660605507324499689
Growth
PAT Growth%
21.317.9-13.055.053.9-1.6-8.4-16.2-36.053.938.2
NPM
NPM%
8.510.611.48.510.816.417.711.99.36.98.911.0
EPS
EPS
81.192.5109.094.8145.7224.7221.2204.2174.2109.5164.4230.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
303030303030303030292929
Reserves
ReservesCr
1,0091,5851,9362,2142,6763,1253,7974,3994,6425,0855,5696,193
Current Liabilities
Current LiabilitiesCr
6387065885695777328069998408888841,122
Non Current Liabilities
Non Current LiabilitiesCr
140156158181237237274248208424455482
Total Liabilities
Total LiabilitiesCr
1,8232,4792,7273,0143,5444,1504,9375,7065,7686,4767,0017,900
Current Assets
Current AssetsCr
1,0411,0591,1271,3551,6622,0822,5642,6892,0912,2762,9454,056
Non Current Assets
Non Current AssetsCr
7821,4201,6001,6581,8822,0692,3733,0173,6774,2014,0563,845
Total Assets
Total AssetsCr
1,8232,4792,7273,0143,5444,1504,9375,7065,7686,4767,0017,900

Cash Flow

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
3064013923564048817182317076676031,023
Investing Cash Flow
Investing Cash FlowCr
-167-375-173-130-407-783-646-168-469-683-495-895
Financing Cash Flow
Financing Cash FlowCr
-124-39-212-207-1-111-52-57-25738-118-98
Net Cash Flow
Net Cash FlowCr
16-13718-5-12196-2022-1030
Free Cash Flow
Free Cash FlowCr
12931180213195508396-359-167164334
CFO To PAT
CFO To PAT%
135.4146.2121.2126.592.6131.4108.838.3139.5205.9120.9148.4
CFO To EBITDA
CFO To EBITDA%
76.387.376.970.452.697.778.325.491.2104.866.199.2

Ratios

Consolidated
Standalone
Financial YearMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3,3454,5707,0597,77710,59711,78920,93530,44020,54416,89418,05818,763
Price To Earnings
Price To Earnings
14.216.721.928.124.517.731.950.440.052.337.327.7
Price To Sales
Price To Sales
1.31.82.52.22.62.95.66.03.83.63.23.0
Price To Book
Price To Book
3.22.83.63.53.93.75.56.94.43.33.23.0
EV To EBITDA
EV To EBITDA
8.810.514.115.313.813.122.633.526.526.819.918.3
Profitability Ratios
Profitability Ratios
GPM
GPM%
45.648.949.445.347.851.954.649.047.246.950.837.0
OPM
OPM%
15.117.718.015.319.022.024.617.914.313.516.416.4
NPM
NPM%
8.510.611.48.510.816.417.711.99.36.98.911.0
ROCE
ROCE%
27.622.822.318.824.926.322.517.914.78.612.314.3
ROE
ROE%
21.817.016.412.516.121.317.313.710.86.38.911.1
ROA
ROA%
12.411.111.99.312.316.213.410.68.85.07.18.7
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Atul Ltd, founded on **September 5, 1947**, by **Mr. Kasturbhai Lalbhai**, is one of India’s largest **integrated chemical companies**, with a legacy of over 75 years. Headquartered in Gujarat, the company operates across a diverse portfolio of chemical products and formulations, serving approximately **4,000 customers across 30 industries in around 82–83 countries**. With annual revenue approaching ₹5,000 crore, Atul has evolved from a traditional B2B chemical manufacturer to a diversified enterprise with growing **B2C retail operations** in crop protection and polymers. The company maintains a strong global presence through subsidiaries in **Brazil, China, the UAE, the UK, and the USA**, and manages **eight manufacturing sites** across India (Ankleshwar, Atul, Panoli, Tarapur, Ambernath, Valsad, Jodhpur) and the UK (Somerset). --- ### **Business Segments & Portfolio** Atul operates across a broad and integrated value chain, organized into two primary revenue categories: 1. **Life Science Chemicals** – APIs, intermediates, agrochemicals, bioscience products. 2. **Performance and Other Chemicals** – Aromatics, bulk chemicals, dyes, pigments, polymers, resins, and retail chemicals. #### **Key Sub-Segments (as of May 2025):** | Sub-Segment | Key Products | Industries Served | Market Position | |-------------|--------------|-------------------|-----------------| | **Pharmaceuticals (APIs & Intermediates)** | Dapsone, anti-diabetic, anti-inflammatory APIs | Pharma | 50% market share in India/Europe for Dapsone; FDA-approved Ambernath site | | **Crop Protection – Bulk & Retail** | Herbicides (2,4-D), Insecticides (Indoxacarb), Fungicides, Biostimulants | Agriculture | 13% share in 2,4-D, 15% in Indoxacarb; 58 brands, 71 formulations | | **Polymers – Performance Materials** | Epoxy resins, sulfones, curing agents, reactive diluents | Aerospace, composites, wind energy, electronics | Leading share in India for epoxy resins; significant global sulfone presence | | **Polymers – Retail** | Adhesives (epoxy, PU, synthetic rubber) | Footwear, construction, automotive | Brands: Lapox (7%), Polygrip (5%) – competing with Fevicol, Araldite | | **Colors** | Vat dyes, Sulphur black, High-performance pigments | Textiles, paints, paper | Strong India presence in Vat/Sulphur dyes; limited global pigment share | | **Bulk Chemicals & Intermediates** | Resorcinol, 1,3-CHD, resorcinol resins | Tyres, cosmetics, chemicals | Global leadership in 1,3-CHD; strong domestic resorcinol share | --- ### **Retail Expansion & Brand Portfolio** Atul is actively building two **B2C retail businesses**, both showing strong momentum: - **Crop Protection - Retail**: ₹256 crore sales in FY24–25 (+25% YoY), driven by 39% volume growth. Key brands: **Rymix, Amsac, Lepto, Sindica (launched March 2024)**. - **Polymers - Retail**: Sales from adhesives segment growing steadily. Portfolio includes **3 primary brands, 76 sub-brands, ~600 customers**. Sindica, a **patented post-emergence herbicide** for sugarcane, combines 2,4-D Sodium, Metribuzin, and Chlorimuron ethyl—targeting broadleaf weeds, grasses, and sedges with no adverse soil impact. Commercial launch in India was in **March 2024**, with international market studies underway. --- ### **Subsidiaries & Joint Ventures (as of Jul 2025)** | Entity | Ownership | Key Developments | |--------|-----------|------------------| | **Atul Products (100%)** | Fully owned | Sales up from ₹65Cr to ₹353Cr; expects **PBT positivity by 2025–26** | | **Anaven LLP (50-50 with Nouryon)** | JV | Sales grew from ₹73Cr to ₹86Cr; **EBITDA positive**; ₹125Cr sales potential | | **Atul Rajasthan Date Palms (74-26 Govt. of Rajasthan)** | JV | Technology refinement ongoing; output expected to improve gradually | | **Atul Bioscience Ltd (100%)** | Fully owned | Sales: ₹132Cr → ₹137Cr; **USFDA approval at Ambernath**; zero 483 observations; launched 2 new products in U.S./EU | | **DPD (98%)** | Majority-owned | Sales: £4.7M → £5M; potential for **50% growth**; capacity doubled in 2020 | | **Rudolf Atul Chemicals Ltd (RACL) (50-50)** | JV with Rudolf Group | Record sales of ₹167Cr, PBT ₹36Cr; aims to grow market share in textile chemicals | --- ### **Financial Performance (2024–25)** - **Total Revenue**: ₹4,719.12 crore - External: ₹4,533.06 crore - Inter-segment: ₹240.47 crore (evidencing strong internal integration) - **Exports**: ₹2,187.87 crore (**43% of turnover**) - **Life Science Chemicals**: ₹1,519.96 crore (up from ₹1,257.29Cr) - **Performance & Other Chemicals**: ₹3,730.09 crore (up from ₹3,272.86Cr) --- ### **Innovation & R&D** - **R&D Investment**: ₹41 crore (Jul 2025), supported by **10 labs and 242 researchers**. - Focus on **APIs, agrochemicals, polymers, dyes**, and sustainable chemistry. - **Atul Bioscience**: Scaling up two products, commercializing two new APIs and intermediates. - Multiple **new product launches** in crop protection and polymers (10 in 2024–25). --- ### **Sustainability & Infrastructure** - **Zero Liquid Discharge (ZLD)**: Achieved at **five manufacturing sites**. - **Captive Power**: 73 MW - **Effluent Treatment**: 32 MLD capacity - **Backward Integration**: Strong cost control via in-house production of key intermediates. - **Debt-free balance sheet** – funded via internal accruals and shareholder capital. --- ### **Manufacturing & Operations** - **8 consolidated manufacturing sites** across India and the UK. - Portfolio of **~900 products, 400 formulations, 140 brands**. - **1,300+ employees** (approx. 3,000 across group), ~3,643 suppliers, ~2,000 distributors, ~38,000 retailers. - **Digital transformation** underway: enhancing website, social media, and channel engagement. --- ### **Growth Strategy (as of 2025)** 1. **Organic Expansion**: - Launch new products in crop protection, polymers, and life sciences. - Strengthen distribution in India and expand geographically. 2. **Retail Scale-Up**: - Accelerate **Crop Protection** and **Polymers Retail** businesses. - Target **₹250–350 crore+ sales** in each retail segment. 3. **Capacity Utilization**: - Maximize output at new plants (e.g., Anaven MCA facility, new Polymers plant). - Debottlenecking and capacity expansion in para-Cresol, resorcinol, dyes. 4. **Market Penetration**: - Increase presence in **epoxy, wind energy, technical textiles, adhesives**. - Expand RACL’s footprint in **denim, printing, synthetic textiles**. 5. **Inorganic Opportunities**: - Evaluate strategic acquisitions in Fragrance, Personal Care, and Crop Protection. 6. **Sustainability**: - Promote green chemistry, energy efficiency, and circular processes.